Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis
Molecular Psychiatry · 2024
DOI: 10.1038/s41380-024-02452-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Psychiatry, 2024. Verfasst von Paolo Preziosa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Gray Matter, Multiple Sclerosis, Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
In multiple sclerosis (MS), a non-random and clinically relevant pattern of gray matter (GM) volume loss has been described. Whether differences in regional gene expression might underlay distinctive pathological processes contributing to this regional variability has not been explored yet. Two hundred eighty-six MS patients and 172 healthy controls (HC) underwent a brain 3T MRI, a complete neurological evaluation and a neuropsychological assessment. Using Allen Human Brain Atlas, voxel-based morphometry and MENGA platform, we integrated brain transcriptome and neuroimaging data to explore the spatial cross-correlations between regional GM volume loss and expressions of 2710 genes involved in MS (p < 0.05, family-wise error-corrected). Enrichment analyses were performed to evaluate overrepresented molecular functions, biological processes and cellular components involving genes significantly associated with voxel-based morphometry-derived GM maps (p < 0.05, Bonferroni-corrected). A diffuse GM volume loss was found in MS patients compared to HC and it was spatially correlated with 74 genes involved in GABA neurotransmission and mitochondrial oxidoreductase activity mainly expressed in neurons and astrocytes. A more severe GM volume loss was spatially associated, in more disabled MS patients, with 44 genes involved in mitochondrial integrity of all resident cells of the central nervous system (CNS) and, in cognitively impaired MS patients, with 64 genes involved in mitochondrial protein heterodimerization and oxidoreductase activities expressed also in microglia and endothelial cells. Specific differences in the expressions of genes involved in synaptic GABA receptor activities and mitochondrial functions in resident CNS cells may influence regional susceptibility to MS-related excitatory/inhibitory imbalance and oxidative stress, and subsequently, to GM volume loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. rocca.mara@hsr.it.
ORCID-Profile: Paolo Preziosa, Nicolò Tedone, Massimo Filippi, Maria A Rocca
Zitieren
APA
Preziosa, P., Storelli, L., Tedone, N., Margoni, M., Mistri, D., Azzimonti, M., Filippi, M., & Rocca, M. A. (2024). Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis. Molecular Psychiatry. https://doi.org/10.1038/s41380-024-02452-5
Vancouver
Preziosa P, Storelli L, Tedone N, Margoni M, Mistri D, Azzimonti M, et al. Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis. Molecular Psychiatry. 2024. doi:10.1038/s41380-024-02452-5
BibTeX
@article{Preziosa2024,
author = {Preziosa, Paolo and Storelli, Loredana and Tedone, Nicolò and Margoni, Monica and Mistri, Damiano and Azzimonti, Matteo and Filippi, Massimo and Rocca, Maria A},
title = {Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis},
journal = {Molecular Psychiatry},
year = {2024},
doi = {10.1038/s41380-024-02452-5}
}
EUVIMED